American Journal of Kidney Diseases
Volume 55, Issue 1 , Pages 121-131, January 2010

Polymicrobial Peritonitis in Peritoneal Dialysis Patients in Australia: Predictors, Treatment, and Outcomes

  • Katherine Barraclough, MD

      Affiliations

    • Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    • Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
  • ,
  • Carmel M. Hawley, MMedSci

      Affiliations

    • Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    • Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
  • ,
  • Stephen P. McDonald, PhD

      Affiliations

    • Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    • Department of Nephrology and Transplantation Services, University of Adelaide at the Queen Elizabeth Hospital, Adelaide, Australia
  • ,
  • Fiona G. Brown, PhD

      Affiliations

    • Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    • Department of Nephrology, Monash Medical Center, Clayton, Victoria, Australia
  • ,
  • Johan B. Rosman, MD

      Affiliations

    • Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    • Renal Department, Middlemore Hospital, Otahuhu, Auckland, New Zealand
  • ,
  • Kathryn J. Wiggins, MD

      Affiliations

    • Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    • University of Melbourne Department of Medicine, St Vincent's Hospital, Fitzroy, Victoria, Australia
  • ,
  • Kym M. Bannister, MD

      Affiliations

    • Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    • Department of Nephrology, Royal Adelaide Hospital, Adelaide, Australia
  • ,
  • David W. Johnson, PhD

      Affiliations

    • Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
    • Department of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia
    • Corresponding Author InformationAddress correspondence to David W. Johnson, PhD, Department of Nephrology, Level 2, ARTS Bldg, Princess Alexandra Hospital, Ipswich Rd, Woolloongabba, Brisbane Qld 4102, Australia

Received 11 May 2009; accepted 21 August 2009. published online 23 November 2009.

Background

The study aim was to examine the frequency, predictors, treatment, and clinical outcomes of peritoneal dialysis–associated polymicrobial peritonitis.

Study Design

Observational cohort study using ANZDATA (The Australia and New Zealand Dialysis and Transplant Registry) data.

Setting & Participants

All Australian peritoneal dialysis patients between October 2003 and December 2006.

Predictors

Age, sex, race, body mass index, baseline renal function, late referral, kidney disease, smoking status, comorbidity, peritoneal permeability, center, state, organisms, and antibiotic regimen.

Outcomes & Measurements

Polymicrobial peritonitis occurrence, relapse, hospitalization, catheter removal, hemodialysis transfer, and death.

Results

359 episodes of polymicrobial peritonitis occurred in 324 individuals, representing 10% of all peritonitis episodes during 6,002 patient-years. The organisms isolated included mixed Gram-positive and Gram-negative organisms (41%), pure Gram-negative organisms (22%), pure Gram-positive organisms (25%), and mixed bacteria and fungi (13%). There were no significant independent predictors of polymicrobial peritonitis except for the presence of chronic lung disease. Compared with single-organism infections, polymicrobial peritonitis was associated with higher rates of hospitalization (83% vs 68%; P < 0.001), catheter removal (43% vs 19%; P < 0.001), permanent hemodialysis transfer (38% vs 15%; P < 0.001), and death (4% vs 2%; P = 0.03). Isolation of fungus or Gram-negative bacteria was the primary predictor of adverse clinical outcomes. Pure Gram-positive peritonitis had the best clinical outcomes. Patients who had their catheters removed >1 week after polymicrobial peritonitis onset were significantly more likely to be permanently transferred to hemodialysis therapy than those who had earlier catheter removal (92% vs 81%; P = 0.05).

Limitations

Limited covariate adjustment. Residual confounding and coding bias could not be excluded.

Conclusions

Polymicrobial peritonitis can be treated successfully using antibiotics alone without catheter removal in most cases, particularly when only Gram-positive organisms are isolated. Isolation of Gram-negative bacteria (with or without Gram-positive bacteria) or fungi carries a worse prognosis and generally should be treated with early catheter removal and appropriate antimicrobial therapy.

Index Words: Antibiotics, bacteria, fungi, microbiology, peritonitis, outcomes

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Originally published online as doi:10.1053/j.ajkd.2009.08.020 on November 23, 2009.

PII: S0272-6386(09)01190-1

doi:10.1053/j.ajkd.2009.08.020

American Journal of Kidney Diseases
Volume 55, Issue 1 , Pages 121-131, January 2010